Real-time PCR applications for diagnosis of leishmaniasis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
mucocutaneous leishmaniasis 2 infectiousdiseases
visceral leishmaniasis 2 infectiousdiseases
cutaneous leishmaniasis 5 infectiousdiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
cutaneous leishmaniasis 543 heterogeneous clinical manifestations ranging from asymptomatic infections to lesions at cutaneous sites ( cutaneous leishmaniasis ), mucosal sites (mucocutaneous leishmaniasis) or in visceral organs (visceral leishmaniasis), depending
cutaneous leishmaniasis 588 asymptomatic infections to lesions at cutaneous sites (cutaneous leishmaniasis), mucosal sites (muco cutaneous leishmaniasis ) or in visceral organs (visceral leishmaniasis), depending on the species and host characteristics.
cutaneous leishmaniasis 2072 characteristics, the infection can be asymptomatic or it can lead to a spectrum of diseases, notably cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) or mucocutaneous leishmaniasis (MCL). About 12 million people are
cutaneous leishmaniasis 2137 to a spectrum of diseases, notably cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) or muco cutaneous leishmaniasis (MCL). About 12 million people are affected by the disease; moreover, 0.2–0.4 million cases per year
cutaneous leishmaniasis 35867 melting step analysis was developed to discriminate between L. (L.) major and L. (L.) tropica causing cutaneous leishmaniasis in Iran [[37]].Melting analysis was also performed using fluorescence resonance energy transfer (FRET)
mucocutaneous leishmaniasis 584 from asymptomatic infections to lesions at cutaneous sites (cutaneous leishmaniasis), mucosal sites ( mucocutaneous leishmaniasis ) or in visceral organs (visceral leishmaniasis), depending on the species and host characteristics.
mucocutaneous leishmaniasis 2133 lead to a spectrum of diseases, notably cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) or mucocutaneous leishmaniasis (MCL). About 12 million people are affected by the disease; moreover, 0.2–0.4 million cases per year
visceral leishmaniasis 636 sites (cutaneous leishmaniasis), mucosal sites (mucocutaneous leishmaniasis) or in visceral organs ( visceral leishmaniasis ), depending on the species and host characteristics. Often, symptoms are inconclusive and leishmaniasis
visceral leishmaniasis 2102 can be asymptomatic or it can lead to a spectrum of diseases, notably cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) or mucocutaneous leishmaniasis (MCL). About 12 million people are affected by the disease; moreover,

You must be authorized to submit a review.